Short Summary
Berkshire Hathaway Energy’s subsidiaries IPL and WPL settled with patent owner Birchtech Corp., prompting a joint motion to terminate the inter partes review of patent 10,596,517 for those parties.
Detailed Summary
In IPR2025-00281, Berkshire Hathaway Energy Company and its constituent petitioners sought to terminate the inter partes review of U.S. Patent No. 10,596,517 with respect to Interstate Power & Light Company and Wisconsin Power & Light Company following executed settlement agreements with patent owner Birchtech Corp. The motion cites 35 U.S.C. §317(a) and (b), noting that no merits decision has been rendered and emphasizing public policy favoring settlement. Related proceedings include other IPRs (IPR2025-00280, IPR2025-01118) and an MDL in the Southern District of Iowa. The Board’s decision on the motion remains pending.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Berkshire Hathaway Energy Company et al. vs MES, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Cambridge Mobile Telematics, Inc.vsSfara, Inc.
Cambridge Mobile Telematics challenged 18 of Sfara, Inc.'s crash detection claims in an IPR petition, arguing they are rendered obvious by prior art references Green and Wright. The petitioner asserts that combining existing sensor technologies with methods for logging driving information allows a Person Having Ordinary Skill in the Art (POSITA) to achieve the claimed features.
iRhythm, Inc.vsWelch Allyn, Inc. et al.
iRhythm challenges the PTAB Acting Director’s denial of five IPR petitions on the ground that a newly issued ‘settled expectations’ rule was applied retroactively. The company argues the rule conflicts with precedent and statutory limits, and would burden the PTAB and stifle innovation.
Ciena CorporationvsK.Mizra LLC
The USPTO Director denied Ciena's request for review of the institution decision in IPR2025-01362, leaving the denial of institution in place. No substantive patentability issues were addressed.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB instituted an IPR on Inari Medical’s 11,697,012 patent covering hemostasis valves for aspiration catheters after finding a reasonable likelihood that Imperative Care will prevail on at least one of the nine challenged claims.
Amazon.com, Inc. et al.vsAlmondNet, Inc.
Amazon has filed an IPR petition seeking to invalidate dozens of claims of AlmondNet’s ’904 patent covering URL‑redirect based user profiling for targeted ads.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.